Vps33b regulates Vwf-positive vesicular trafficking in megakaryocytes

Journal of Pathology

Volumn 240, Issue 1, 2016, Pages 108-119

  Dai, Jing ^a   Lu, Yeling ^a   Wang, Conghui ^a   Chen, Xue ^a   Fan, Xuemei ^a   Gu, Hao ^a   Wu, Xiaolin ^a   Wang, Kemin ^a   Gartner, T Kent ^b   Zheng, Junke ^a   Chen, Guoqiang ^a   Wang, Xuefeng ^a   Liu, Junling ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b University of Memphis   (United States)

Author keywords

megakaryocyte; platelet; vesicle trafficking; VPS33B complex; granules

Indexed keywords

ALPHA TUBULIN; CELL PROTEIN; SEC22B PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; VIPAS39 PROTEIN; VON WILLEBRAND FACTOR; VPS33B PROTEIN;

ANIMAL CELL; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; EMBRYO; FETUS; GENE; GENE DELETION; HEK293 CELL LINE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; THROMBOCYTE; VPS33B GENE;

EID: 84983334837     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4762     Document Type: Article

References (53)

1. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nature Rev Immunol 2011; 11: 264–274.
2. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
3. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nature Rev Cancer 2011; 11: 123-134.
4. Richardson JL, Shivdasani RA, Boers C, et al. Mechanisms of organelle transport and capture along proplatelets during platelet production. Blood 2005; 106: 4066-4075.
5. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009; 23: 177-189.
6. Italiano JE Jr, Battinelli EM. Selective sorting of alpha-granule proteins. J Thromb Haemost 2009; 7 (Suppl 1): 173-176.
7. Niewiarowski S. Proteins secreted by the platelet. Thromb Haemost 1977; 38: 924-938.
8. Reed GL, Fitzgerald ML, Polgar J. Molecular mechanisms of platelet exocytosis: insights into the ‘secrete’ life of thrombocytes. Blood 2000; 96: 3334-3342.
9. Fukami H, Holmsen H, Kowalska MA, et al. Platelet secretion. In Haemostasis and Thrombosis: Basic Principles and Clinical Practice (4th edn), Colman RW, Hirsch J, Marder V, et al (eds). Lippincott Williams &Wilkins: Philadelphia, PA, 2001; 561–573.
10. Sixma JJ, Slot JW, Geuze HJ. Immunocytochemical localization of platelet granule proteins. Methods Enzymol 1989; 169: 301-311.
11. Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003; 10: 335-350.
12. Youssefian T, Cramer EM. Megakaryocyte dense granule components are sorted in multivesicular bodies. Blood 2000; 95: 4004-4007.
13. Heijnen HF, Debili N, Vainchencker W, et al. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 1998; 91: 2313-2325.
14. Cramer EM, Vainchenker W, Vinci G, et al. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood 1985; 66: 1309-1316.
15. Breton-Gorius J, Vainchenker W, Nurden A, et al. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol 1981; 102: 10-19.
16. Levy-Toledano S, Caen JP, Breton-Gorius J, et al. Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function. J Lab Clin Med 1981; 98: 831-848.
17. Nurden AT, Kunicki TJ, Dupuis D, et al. Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome. Blood 1982; 59: 709-718.
18. Gebrane-Younes J, Cramer EM, Orcel L, et al. Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells. J Clin Invest 1993; 92: 3023-3028.
19. Albers CA, Cvejic A, Favier R, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nature Genet 2011; 43: 735-737.
20. Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet alpha-granules. Nature Genet 2011; 43: 732-734.
21. Kahr WH, Hinckley J, Li L, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nature Genet 2011; 43: 738-740.
22. −/− mice. Blood 2013; 122: 3349-3358.
23. Deppermann C, Cherpokova D, Nurden P, et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest 2013; 123: 3331-3342.
24. −/− mouse as a model for the gray platelet syndrome. Rare Dis 2013; 1: e26561.
25. Lo B, Li L, Gissen P, et al. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood 2005; 106: 4159-4166.
26. Jang JY, Kim KM, Kim GH, et al. Clinical characteristics and VPS33B mutations in patients with ARC syndrome. J Pediatr Gastroenterol Nutr 2009; 48: 348-354.
27. Gissen P, Johnson CA, Morgan NV, et al. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome. Nature Genet 2004; 36: 400-404.
28. Cullinane AR, Straatman-Iwanowska A, Seo JK, et al. Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome. Hum Mutat 2009; 30: E330-E337.
29. Cullinane AR, Straatman-Iwanowska A, Zaucker A, et al. Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization. Nature Genet 2010; 42: 303-312.
30. Urban D, Li L, Christensen H, et al. The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet alpha-granule biogenesis. Blood 2012; 120: 5032-5040.
31. Bem D, Smith H, Banushi B, et al. VPS33B regulates protein sorting into and maturation of alpha-granule progenitor organelles in mouse megakaryocytes. Blood 2015; 126: 133-143.
32. Xiang B, Zhang G, Ye S, et al. Characterization of a novel integrin binding protein, VPS33B, which is important for platelet activation and in vivo thrombosis and hemostasis. Circulation 2015; 132: 2334-2344.
33. Gothert JR, Gustin SE, Hall MA, et al. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 2005; 105: 2724-2732.
34. Weng Z, Li D, Zhang L, et al. PTEN regulates collagen-induced platelet activation. Blood 2010; 116: 2579-2581.
35. Liu J, Jackson CW, Gruppo RA, et al. The β3 subunit of the integrin αIIbβ3 regulates αIIb-mediated outside-in signaling. Blood 2005; 105: 4345-4352.
36. Eto K, Murphy R, Kerrigan SW, et al. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A 2002; 99: 12819-12824.
37. Bender M, Stritt S, Nurden P, et al. Megakaryocyte-specific Profilin1-deficiency alters microtubule stability and causes a Wiskott–Aldrich syndrome-like platelet defect. Nature Commun 2014; 5: 4746.
38. Pevsner J, Hsu SC, Hyde PS, et al. Mammalian homologues of yeast vacuolar protein sorting (vps) genes implicated in Golgi-to-lysosome trafficking. Gene 1996; 183: 7-14.
39. Rizo J, Sudhof TC. The membrane fusion enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices – guilty as charged? Annu Rev Cell Dev Biol 2012; 28: 279-308.
40. Ma C, Su L, Seven AB, et al. Reconstitution of the vital functions of Munc18 and Munc13 in neurotransmitter release. Science 2013; 339: 421-425.
41. Rizo J. Cell biology. Staging membrane fusion. Science 2012; 337: 1300-1301.
42. Pulipparacharuvil S, Akbar MA, Ray S, et al. Drosophila Vps16A is required for trafficking to lysosomes and biogenesis of pigment granules. J Cell Sci 2005; 118: 3663-3673.
43. Suzuki T, Oiso N, Gautam R, et al. The mouse organellar biogenesis mutant buff results from a mutation in Vps33a, a homologue of yeast vps33 and Drosophila carnation. Proc Natl Acad Sci U S A 2003; 100: 1146-1150.
44. Graham SC, Wartosch L, Gray SR, et al. Structural basis of Vps33A recruitment to the human HOPS complex by Vps16. Proc Natl Acad Sci U S A 2013; 110: 13345-13350.
45. Baker RW, Jeffrey PD, Hughson FM. Crystal structures of the Sec1/Munc18 (SM) protein Vps33, alone and bound to the homotypic fusion and vacuolar protein sorting (HOPS) subunit Vps16*. PloS One 2013; 8: e67409.
46. van der Kant R, Jonker CT, Wijdeven RH. Characterization of the mammalian CORVET and HOPS complexes and their modular restructuring for endosome specificity. J Biol Chem 2015; 290: 30280-30290.
47. Sudhof TC, Rizo J. Synaptic vesicle exocytosis. Cold Spring Harb Perspect Biol 2012; 4: a005645.
48. Zhou Y, Zhang J. Arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome: from molecular genetics to clinical features. Ital J Pediatr 2014; 40: 77.
49. Mimori Y, Miki-Noumura T. Extrusion of rotating microtubules on the dynein-track from a microtubule-dynein γ-complex. Cell Motil Cytoskeleton 1995; 30: 17-25.
50. Cebrian I, Visentin G, Blanchard N, et al. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 2011; 147: 1355-1368.
51. Petkovic M, Jemaiel A, Daste F, et al. The SNARE Sec22b has a non-fusogenic function in plasma membrane expansion. Nature Cell Biol 2014; 16: 434-444.
52. Tornieri K, Zlatic SA, Mullin AP, et al. Vps33b pathogenic mutations preferentially affect VIPAS39/SPE-39-positive endosomes. Hum Mol Genet 2013; 22: 5215-5228.
53. Galmes R, Ten Brink C, Oorschot V, et al. Vps33B is required for delivery of endocytosed cargo to lysosomes. Traffic 2015; 16: 1288-1305.